← Leaderboards
Antonella M Borgatti
University Of Minnesota
$1,234,695
Attributed
$1,730,704
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $503.9K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,730,704 · 2
By mechanism
R01$992,018 · 1
K01$738,686 · 1
Top collaborators
- George V Aslanidi2 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Christopher A Pennell$7,545,730
- George V Aslanidi$2,567,167
Others in their field
Top investigators on “Toxic Effect”
- George R Seage · Abt Associates, Inc.$224,114,540
- Peter C Adamson · National Childhood Cancer Foundation$126,756,857
- Gregory H Reaman · National Childhood Cancer Foundation$123,836,183
- Carol Nesel · Westat$116,355,411
- Mary M Horowitz · Medical College Of Wisconsin$90,165,506
- Barney Sparrow · Battelle Memorial Institute$88,494,220
Research focus
Toxic EffectChemotherapyFlow CytometrySafetyMalignant NeoplasmsNeoplasm MetastasisDisease ProgressionDoseIn VivoProgramsTreatment OutcomeTumorAnimal ModelAdjuvantBasic ScienceDesignCanis FamiliarisBiomedical EngineeringCellsCompanion AnimalBaseAntineoplastic AgentsCancer PatientComparative
Grant awards (7)
Development of novel AAV vaccine strategy in a pre-clinical model of oral melanoma.$488,155
R01 · FY2025 · CA
Development of novel AAV vaccine strategy in a pre-clinical model of oral melanoma.$503,863
R01 · FY2024 · CA
Preclinical evaluation and clinical translation of novel bispecific toxins that t$147,341
K01 · FY2018 · OD · contact PI
Preclinical evaluation and clinical translation of novel bispecific toxins that t$147,504
K01 · FY2017 · OD · contact PI
Preclinical evaluation and clinical translation of novel bispecific toxins that t$147,729
K01 · FY2016 · OD · contact PI
Preclinical evaluation and clinical translation of novel bispecific toxins that t$147,948
K01 · FY2015 · OD · contact PI
Preclinical evaluation and clinical translation of novel bispecific toxins that t$148,164
K01 · FY2014 · OD · contact PI